background
upper
respiratori
tract
infect
symptom
common
caus
morbid
herbal
prepar
plant
echinacea
purpurea
immuneenhanc
properti
object
compar
frequenc
upper
respiratori
tract
symptom
individu
receiv
e
purpurea
capsul
receiv
placebo
evalu
prevent
efficaci
echinacea
method
random
doubleblind
clinic
trial
volunt
recruit
hospit
personnel
randomli
assign
receiv
capsul
twice
daili
either
placebo
parsley
e
purpurea
week
winter
month
upper
respiratori
tract
symptom
report
weekli
period
result
fiftyeight
individu
includ
final
data
analysi
echinacea
group
placebo
group
individu
echinacea
group
report
sick
day
per
person
period
wherea
placebo
group
report
sick
day
z
p
mild
advers
effect
note
echinacea
group
placebo
group
p
conclus
prophylact
treatment
commerci
avail
e
purpurea
capsul
significantli
alter
frequenc
upper
respiratori
tract
symptom
compar
placebo
use
upper
respiratori
tract
infect
common
caus
morbid
gener
discomfort
miss
day
work
symptom
frequent
encount
winter
flu
season
differ
virus
caus
common
cold
adult
includ
rhinoviru
frequent
caus
coronaviru
adenovirus
respiratori
syncyti
viru
parainfluenza
virus
unit
state
averag
adult
develop
cold
children
cold
year
herbal
prepar
leav
root
plant
echinacea
purpurea
increas
phagocyt
cell
spleen
bone
marrow
act
phytoimmun
modul
immun
system
enhanc
vitro
studi
support
claim
immun
modul
indic
effect
may
mediat
modif
activ
polymorphonuclear
neutrophil
granulocyt
macrophag
echinaceacontain
prepar
extens
use
treatment
prevent
infect
apart
allerg
reaction
increas
incid
rash
report
gener
safe
clinic
trial
test
abil
echinacea
prevent
cold
amelior
symptom
mix
result
cochran
review
found
avail
studi
report
benefit
echinacea
use
variat
prepar
echinacea
use
methodolog
qualiti
limit
conclus
recent
metaanalysi
found
standard
echinacea
extract
effect
prevent
symptom
common
cold
clinic
inocul
methodolog
shortcom
studi
herbal
medicin
includ
echinacea
note
research
well
metaanalysi
studi
publish
sinc
suggest
echinacea
effect
treat
cold
prevent
although
efficaci
echinacea
conclus
demonstr
million
prescript
echinacea
prepar
germani
use
nonprescript
herbal
remedi
undoubtedli
higher
almost
patient
us
health
mainten
organ
indic
use
herbal
remedi
echinacea
rank
fifth
herbal
medicin
sale
address
methodolog
shortcom
identifi
previou
echinacea
studi
use
random
doubleblind
placebocontrol
clinic
trial
design
answer
follow
question
commonli
use
echinacea
prepar
prevent
reduc
upper
respiratori
tract
infect
symptom
studi
approv
univers
california
san
francisco
institut
review
board
research
complet
part
requir
complet
famili
medicin
resid
program
univers
california
san
franciscofresno
reason
conveni
sampl
healthi
adult
work
univers
medic
center
famili
health
center
includ
resid
staff
faculti
nurs
staff
serv
particip
studi
popul
expect
equit
exposur
coldinfluenza
recruit
consist
flyer
distribut
univers
medic
center
famili
health
center
particip
voluntari
particip
reimburs
nineti
volunt
age
year
recruit
hospit
personnel
novemb
decemb
project
describ
written
inform
consent
obtain
particip
person
known
immun
dysfunct
undergo
immunosuppress
therapi
pregnant
lactat
women
person
allergi
echinacea
parsley
exclud
individu
characterist
age
raceethn
tobacco
use
presenc
allerg
rhiniti
use
upper
respiratori
tract
infect
prevent
measur
herb
vitamin
medic
administr
influenza
vaccin
record
individu
current
use
echinacea
consid
studi
wherea
use
upper
respiratori
tract
infect
prevent
measur
allow
continu
use
particip
given
suppli
medicin
enrol
particip
randomli
assign
either
experiment
control
group
list
gener
use
randomnumb
gener
spreadsheet
program
microsoft
excel
microsoft
corp
redmond
washington
particip
ask
take
capsul
time
daili
week
either
e
purpurea
mg
per
capsul
parsley
mg
per
capsul
dose
echinacea
similar
recommend
manufactur
type
capsul
provid
compani
indistinguish
size
color
smell
capsul
provid
contain
mark
b
particip
main
investig
person
involv
studi
remain
blind
ident
group
data
analys
complet
particip
contact
telephon
week
train
research
assist
ask
report
number
day
week
experienc
sore
throat
runni
nose
headach
hoars
nasal
congest
muscl
ach
cough
fever
particip
symptom
also
ask
number
day
miss
work
medic
use
treat
symptom
eg
aspirin
acetaminophen
vitamin
cold
formula
number
capsul
miss
week
perceiv
advers
effect
also
record
particip
defin
nonadher
exclud
data
analysi
miss
onethird
recommend
dosag
week
none
person
studi
experienc
seriou
advers
effect
requir
disclosur
group
assign
particip
told
complet
data
analys
whether
experiment
placebo
group
data
enter
databas
program
microsoft
access
microsoft
corp
analyz
use
statist
analysi
softwar
sa
window
releas
sa
institut
inc
cari
north
carolina
prospect
power
analysi
calcul
base
assumpt
effect
size
sampl
size
calcul
provid
suffici
power
detect
differ
cold
frequenc
sd
cold
frequenc
sd
group
miss
data
drop
particip
preclud
intentiontotreat
analysi
perprotocol
analysi
perform
mean
proport
calcul
individu
characterist
test
use
test
differ
group
random
median
number
day
individu
symptom
report
owe
nonnorm
distribut
inform
total
number
day
symptom
calcul
sum
maximum
number
day
report
preval
symptom
week
thu
maximum
possibl
total
number
symptom
day
wilcoxon
rank
sum
test
use
compar
treatment
placebo
group
symptom
total
symptom
day
also
compar
group
week
separ
person
report
symptom
kind
vs
symptom
fisher
exact
test
use
compar
data
nineti
individu
recruit
studi
randomli
assign
either
placebo
echinacea
group
fifteen
individu
echinacea
group
placebo
group
chose
leav
studi
dropout
rate
fig
six
individu
leav
studi
group
port
advers
effect
contribut
studi
discontinu
group
also
nonadher
individu
signific
differ
individu
characterist
reason
dropout
adher
group
random
data
shown
fiftyeight
individu
includ
final
analys
echinacea
group
placebo
group
tabl
individu
characterist
group
individu
random
analyz
signific
differ
echinacea
placebo
group
demograph
characterist
signific
differ
individu
drop
nonadher
complet
studi
person
includ
final
analysi
use
fewer
vitamin
herb
p
report
fewer
allergi
p
tabl
summar
symptom
inform
group
period
symptom
compar
separ
group
signific
differ
found
median
total
number
sick
day
echinacea
group
placebo
group
z
p
mild
advers
effect
note
echinacea
group
placebo
group
p
data
shown
compar
group
week
report
symptom
kind
approxim
particip
report
symptom
week
differ
group
fig
individu
either
group
report
symptom
less
half
treat
symptom
even
fewer
miss
work
placebo
group
consist
report
symptom
given
week
echinacea
group
treat
often
howev
none
differ
statist
signific
found
differ
total
symptom
day
individu
respiratori
symptom
patient
take
prophylact
echinacea
week
compar
take
parsley
capsul
find
consist
recent
studi
demonstr
effect
echinacea
prevent
upper
respiratori
tract
infect
conceiv
echinacea
actual
reduc
total
number
symptom
day
studi
simpli
small
detect
underli
differ
assum
varianc
observ
signific
level
power
group
size
particip
provid
number
suffici
detect
prophylact
echinacea
effect
total
symptom
day
retain
analyz
enrol
individu
detect
differ
would
reduc
total
symptom
day
saw
actual
differ
day
median
total
number
data
given
number
percentag
except
indic
otherwis
statist
test
compar
echinacea
group
placebo
group
echinacea
placebo
group
drop
group
age
test
use
test
categor
data
test
use
test
b
statist
signific
level
combin
echinacea
placebo
group
compar
drop
group
statist
signific
differ
echinacea
placebo
group
use
wilcoxon
rank
sum
test
b
number
percentil
number
percentil
c
total
sick
day
sum
preval
symptom
week
symptom
day
total
number
symptom
day
rang
echinacea
group
placebo
group
assum
actual
reduct
total
symptom
day
echinacea
use
pergroup
sampl
size
would
requir
detect
reduct
power
signific
rel
larg
number
unanalyz
individu
drop
took
less
onethird
schedul
dose
may
bias
result
exclud
individu
also
differ
studi
particip
report
less
herbal
remedi
use
fewer
allergi
symptom
differ
suggest
dropout
peopl
less
afflict
respiratori
symptom
less
preoccupi
prevent
one
might
specul
burden
adher
protocol
excess
group
dropout
nonadher
particip
evenli
distribut
control
intervent
group
anoth
limit
studi
use
health
care
profession
particip
make
difficult
gener
find
group
record
particip
sex
character
find
variabl
neither
control
prevent
measur
may
taken
studi
particip
possibl
bias
find
outcom
collect
drop
preclud
intentiontotreat
analysi
howev
equal
number
dropout
arm
coupl
find
effect
symptom
day
take
echinacea
suggest
intentiontotreat
analysi
would
like
chang
conclus
studi
use
dri
plant
extract
argu
anoth
echinacea
formul
might
efficaci
systemat
review
fail
identifi
therapeut
distinct
echinacea
prepar
studi
involv
use
readili
avail
overthecount
product
wide
use
public
although
none
suspect
parsley
effect
respiratori
symptom
could
expect
find
might
differ
use
truli
inert
placebo
medlin
search
parsley
respiratori
tract
infect
yield
result
allopath
medicin
much
learn
altern
therapi
howev
research
conduct
greater
power
detect
differ
outcom
account
dropout
rate
standard
dose
effect
find
random
control
trial
suggest
echinacea
meaning
effect
respiratori
tract
infect
symptom
